Ruxolitinib in Combination With Pemetrexed/Cisplatin in Non Small Cell Lung Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Gerard T Kennealey, MD
Incyte Corporation
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
30 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Facility name not stated
Phoenix, Arizona, United States
- Facility name not stated
Fayetteville, Arkansas, United States
- Facility name not stated
Fresno, California, United States
- Facility name not stated
La Jolla, California, United States
- Facility name not stated
San Diego, California, United States
- Facility name not stated
San Francisco, California, United States
- Facility name not stated
Lone Tree, Colorado, United States
- Facility name not stated
Norwich, Connecticut, United States
- Facility name not stated
Southington, Connecticut, United States
- Facility name not stated
Augusta, Georgia, United States
- Facility name not stated
Joliet, Illinois, United States
- Facility name not stated
Indianapolis, Indiana, United States
- Facility name not stated
Lafayette, Indiana, United States
- Facility name not stated
Kansas City, Kansas, United States
- Facility name not stated
Detroit, Michigan, United States
- Facility name not stated
St Louis, Missouri, United States
- Facility name not stated
Reno, Nevada, United States
- Facility name not stated
Lebanon, New Hampshire, United States
- Facility name not stated
Mount Kisco, New York, United States
- Facility name not stated
New York, New York, United States
- Facility name not stated
Winston-Salem, North Carolina, United States
- Facility name not stated
Canton, Ohio, United States
- Facility name not stated
Portland, Oregon, United States
- Facility name not stated
Chattanooga, Tennessee, United States
- Facility name not stated
Knoxville, Tennessee, United States
- Facility name not stated
Memphis, Tennessee, United States
- Facility name not stated
Ogden, Utah, United States
- Facility name not stated
Leesburg, Virginia, United States
- Facility name not stated
Kennewick, Washington, United States
- Facility name not stated
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 11 Feb 2014
- Primary completion
- 11 Feb 2016
- Completion
- 21 Jun 2016
- Last update posted
- 13 Feb 2018
- Registered enrollment
- 76
- Registry id
- NCT02119650
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.